Loading...
EPCORE FL-2 phase 3 trial of epcoritamab with rituximab and lenalidomide (R2) vs chemoimmunotherapy (CIT) in previously untreated follicular lymphoma (FL): trial in progress
Strati, P. Thompson, P. Andorsky, D. Luminari, S. Linton, K. Patah, P. Mei, J. Joshi, N. Dixit, N. Favaro, E.
Strati, P.
Thompson, P.
Andorsky, D.
Luminari, S.
Linton, K.
Patah, P.
Mei, J.
Joshi, N.
Dixit, N.
Favaro, E.
Abstract
Description
Date
2025
Publisher
Collections
Files
Loading...
Found from Unpaywall
Adobe PDF, 169.09 KB
Keywords
Type
Article
Citation
Strati P, Thompson P, Andorsky D, Luminari S, Linton K, Patah P, et al. EPCORE FL-2 phase 3 trial of epcoritamab with rituximab and lenalidomide (R2) vs chemoimmunotherapy (CIT) in previously untreated follicular lymphoma (FL): trial in progress. Blood. 2025 NOV 3;146:5393-4.